Secora Michael

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
30
Insider Sells Sum
$5.98M

Insider Activity of Secora Michael

According to the SEC Form 4 filings, Secora Michael, being in a position of

  1. Chief Financial Officer at Recursion Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 468124 shares for $3.87M,
    over all time since 2023-06-13, has bought 0 shares, and sold 668124 shares for $5.98M.

The largest sale of all time was on 2023-07-19 and amounted to 25000 shares of Recursion Pharmaceuticals, Inc. for $388,348.

Biography of Secora Michael

No biography is available at this moment.

2024-09-11SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.0054%
$6.32$94,730+2.92%
2024-09-10SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.0053%
$6.17$92,499+4.75%
2024-08-14SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.0057%
$6.35$95,2520%
2024-08-13SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.0057%
$6.35$95,1830%
2024-07-10SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.0054%
$7.24$108,5760%
2024-07-09SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.0054%
$7.32$109,7780%
2024-06-14SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.007%
$9.27$139,082-24.19%
2024-06-13SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
15,000
0.0071%
$9.32$139,799-24.95%
2024-04-17SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
23,124
0.0109%
$7.58$175,349+7.03%
2024-04-16SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0117%
$7.67$191,658+5.03%
2024-03-13SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0117%
$11.03$275,815-23.73%
2024-03-12SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0115%
$10.46$261,375-20.3%
2024-02-14SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0111%
$10.46$261,425-21.25%
2024-02-13SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0104%
$9.86$246,560-12.14%
2024-01-17SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0116%
$10.25$256,348-13.38%
2024-01-16SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0112%
$10.45$261,160-17.6%
2023-12-13SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0106%
$7.59$189,770+10.73%
2023-12-12SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0116%
$7.39$184,868+23.19%
2023-11-15SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0119%
$7.32$182,986+22.1%
2023-11-14SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Financial Officer
25,000
0.0116%
$6.32$157,943+38.05%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.